Table 1.
Comparing 3 reported cases of hepatotoxicity secondary to ibrutinib
| Case No. | 1 | 2 | 3 |
|---|---|---|---|
| Underlying illness | Chronic lymphocytic | Waldenstrom's | Waldenstrom's |
| leukemia | macroglobulinemia | macroglobulinemia | |
| Age, years | 62 | 59 | 77 |
| Sex | Male | Female | Female |
| Abnormal liver function test onset | 2 weeks | 36 weeks | 8 weeks |
| ALT peak, U/L | 1,245 | ~800 | 1,747 |
| AST peak, U/L | 448 | ~3,000 | 1,300 |
| Total bilirubin peak, mg/dL | 35.2 | 13.6 | 20.4 |
| INR peak | Not specified | 7.7 | 1.5 |
| Liver biopsy | Hepatocellular injury + | Hepatocellular injury + | Hepatocellular injury + |
| cholestasis | cholestasis | cholestasis | |
| Recovery time | 12 weeks + | 9 weeks | 7 weeks |
| Outcome | Died from original illness | Full recovery | Full recovery |